Mighty Capital | Activity | F4

Team Portfolio Raise Champions Essays

F4/Mighty Capital/Activity

Mighty Capital Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Milestone

Angle Health raised $600M at a $2.7B valuation. The company has 120% YoY growth, four consecutive profitable quarters, and renewals at 5-7% vs industry 18%. Mighty Capital first backed them in 2022.

Angle Health

Angle Health Mighty Capital

wsj.comSEP 19, 2026

SEP 19, 2026

News

Mighty Capital was named to TIME Magazine's 2026 list of America's Best Venture Capital Firms for the first time. The firm achieved this recognition with relatively small funds and curated portfolio, indicating exceptional performance.

Mighty Capital

Mighty CapitalMighty Capital

linkedin.comSEP 10, 2026

SEP 10, 2026

Investment

Participated in Devplan’s $2.5M seed round for AI-native product and engineering coordination.

Devplan

Devplan Mighty Capital

prweb.comJUN 18, 2026

JUN 18, 2026

New Fund

Closed Fund III with $91M, tripling Fund II and achieving oversubscription in competitive fundraising environment.

Fund III

fundmomentum.vcAPR 22, 2026

APR 22, 2026

Essay

SC Moatti published the 2026 VC Outlook essay covering 5 forces: trillion-dollar private unicorns, CPO-led M&A replacing IPOs, the AI Mag7 emergence, DPI becoming a liquidity survival requirement for GPs, and the Middle East leaping ahead in AI.

Mighty Capital

Mighty CapitalMighty Capital

linkedin.comDEC 28, 2025

DEC 28, 2025

Essay

SC Moatti published 2026 Venture Capital Outlook on AI-driven concentration of power and CPO-led enterprise.

2026 Venture Capital Outlook

linkedin.comDEC 28, 2025

DEC 28, 2025

Exit

Netskope priced its IPO at $19 per share, began trading on Nasdaq Sept 18, 2025 under ticker NTSK at ~$7.3B valuation. Mighty Capital was an early seed investor in Netskope.

Netskope

Netskope Mighty Capital

netskope.comSEP 17, 2025

SEP 17, 2025

Exit

Fabric Genomics, a Mighty Capital portfolio company, was acquired by GeneDx in April 2025.

Fabric Genomics

Fabric Genomics Mighty Capital

tracxn.comAPR 2025

APR 2025